MML Investors Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25M Buy
49,776
+9,396
+23% +$4.51M 0.05% 346
2026
Q1
$19.8M Buy
40,380
+5,269
+15% +$2.86M 0.06% 334
2025
Q4
$20.3M Buy
35,111
+3,749
+12% +$2.12M 0.05% 357
2025
Q3
$15.2M Buy
31,362
+173
+0.6% +$80.5K 0.04% 415
2025
Q2
$12.6M Sell
31,189
-13,810
-31% -$5.77M 0.04% 447
2025
Q1
$22.4M Buy
44,999
+45
+0.1% +$24.4K 0.07% 263
2024
Q4
$23.4M Sell
44,954
-6,359
-12% -$3.5M 0.08% 246
2024
Q3
$31.7M Buy
51,313
+3,386
+7% +$2M 0.12% 187
2024
Q2
$26.5M Sell
47,927
-2,189
-4% -$1.25M 0.11% 200
2024
Q1
$29.1M Buy
50,116
+4,296
+9% +$2.41M 0.12% 188
2023
Q4
$24.3M Buy
45,820
+1,280
+3% +$620K 0.11% 197
2023
Q3
$22.5M Sell
44,540
-1,818
-4% -$969K 0.12% 178
2023
Q2
$24.2M Buy
46,358
+12,027
+35% +$6.49M 0.13% 174
2023
Q1
$19.8M Sell
34,331
-5,169
-13% -$2.91M 0.14% 164
2022
Q4
$21.8M Buy
39,500
+1,078
+3% +$571K 0.14% 158
2022
Q3
$19.5M Buy
38,422
+2,112
+6% +$1.18M 0.15% 155
2022
Q2
$19.7M Buy
36,310
+3,193
+10% +$1.76M 0.15% 154
2022
Q1
$19.6M Buy
33,117
+45
+0.1% +$25.9K 0.14% 163
2021
Q4
$22.1M Buy
33,072
+1,977
+6% +$1.23M 0.16% 139
2021
Q3
$17.8M Buy
31,095
+1,539
+5% +$845K 0.14% 163
2021
Q2
$14.9M Buy
29,556
+1,452
+5% +$685K 0.13% 181
2021
Q1
$12.8M Buy
28,104
+973
+4% +$464K 0.12% 187
2020
Q4
$12.6M Buy
27,131
+6,571
+32% +$3.08M 0.14% 170
2020
Q3
$9.08M Buy
20,560
+2,121
+12% +$876K 0.11% 187
2020
Q2
$6.68M Buy
18,439
+3,844
+26% +$1.29M 0.09% 224
2020
Q1
$4.14M Buy
14,595
+3,012
+26% +$950K 0.07% 254
2019
Q4
$3.76M Buy
11,583
+1,475
+15% +$447K 0.05% 312
2019
Q3
$2.94M Sell
10,108
-1,028
-9% -$294K 0.05% 337
2019
Q2
$3.27M Buy
11,136
+934
+9% +$257K 0.05% 346
2019
Q1
$2.79M Buy
10,202
+1,500
+17% +$373K 0.04% 364
2018
Q4
$1.95M Buy
8,702
+1,230
+16% +$289K 0.04% 425
2018
Q3
$1.82M Buy
7,472
+2,563
+52% +$590K 0.03% 475
2018
Q2
$1.02M Sell
4,909
-369
-7% -$78.3K 0.02% 556
2018
Q1
$1.09M Sell
5,278
-104
-2% -$21.8K 0.02% 522
2017
Q4
$1.02M Buy
5,382
+948
+21% +$182K 0.02% 542
2017
Q3
$839K Buy
4,434
+611
+16% +$111K 0.02% 573
2017
Q2
$667K Buy
3,823
+302
+9% +$50.7K 0.01% 661
2017
Q1
$541K Buy
+3,521
New +$538K 0.01% 426

Other funds holding TMO

MML Investors Services's TMO Position: Q2 2026 in Review

MML Investors Services increased its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, buying an estimated $4.51M and bringing the position to 49,776 shares worth $25M. The position accounts for 0.05% of the portfolio, ranked #346.

MML Investors Services first reported a position in TMO in Q1 2017 and has held it in 38 quarters since. The position peaked at $31.7M in Q3 2024. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • MML Investors Services held 49,776 shares of Thermo Fisher Scientific worth $25M as of Q2 2026.
  • MML Investors Services bought 9,396 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.51M.
  • Thermo Fisher Scientific made up 0.05% of MML Investors Services's portfolio in Q2 2026, its #346 holding.
  • MML Investors Services first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 38 quarters since.
  • MML Investors Services's Thermo Fisher Scientific position peaked at $31.7M in Q3 2024.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.